Jump to content

Oculomucocutaneous syndrome

From Wikipedia, the free encyclopedia
Oculomucocutaneous syndrome
SpecialtyOphthalmology

Oculomucocutaneous syndrome is characterized by keratoconjunctivitis sicca (dry eyes) and the resulting scarring, fibrosis, metaplasia, and shrinkage of the conjunctiva.[1] It is a drug side effect observed in practolol and eperisone. It is speculated that antibodies against drug metabolites cause the syndrome.[2]

References

[edit]
  1. ^ Wright, P (Mar 15, 1975). "Untoward effects associated with practolol administration: oculomucocutaneous syndrome". British Medical Journal. 1 (5958): 595–8. doi:10.1136/bmj.1.5958.595. PMC 1672788. PMID 1125623.
  2. ^ Amos, HE; Lake, BG; Artis, J (Feb 18, 1978). "Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome". British Medical Journal. 1 (6110): 402–4. doi:10.1136/bmj.1.6110.402. PMC 1602979. PMID 146533.